← Leaderboards
Jagpreet Chhatwal
Baylor College Of Medicine
$1,701,252
Attributed
$3,800,375
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$3,800,375 · 3
By mechanism
U01$2,195,783 · 1
P01$926,164 · 1
R01$678,428 · 1
Top collaborators
- Hashem B El-Serag3 shared
- Fasiha Kanwal3 shared
- Eugene J Koay3 shared
- Prasad G. Iyer1 shared
- John Kisiel1 shared
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Mamoun Younes$1,450,283
- Sharmila Anandasabapathy$9,395,698
- Christopher I. Amos$46,081,488
- David John Tweardy$14,168,425
- Mimi Chang Tan$794,861
Others in their field
Other Rising Stars on “Cost”
- Katherine M Thibault · Battelle Memorial Institute$134,148,552
- Richard Smith · Medical Device Innovation Consortium$41,401,350
- Thierry Diagana · University Of Texas Med Br Galveston$37,506,320
- Julia Louise Moore Vogel · Scripps Research Institute, The$32,252,685
- Tim A Bertram · Wake Forest University School Of Medicine$30,163,580
- Supriya Menezes · The Emmes Company, Llc$25,277,032
Research focus
CostInnovationBiological MarkersScreeningRisk FactorsGuidelinesCohortScreening For CancerReportingSerumMorbidity - Disease RateMortalityPrimary Carcinoma Of The Liver CellsComparativeProgramsHepatitis CCirrhosisHigh RiskCost EffectivenessImageModalityMathematical ModelProspectiveSeverities
Grant awards (8)
Risk Stratification for and Early Detection of Liver Cancer$798,777
U01 · FY2025 · CA
Minimally Invasive Molecular Approaches for the Detection of Barrettâs Esophagus and Esophageal Adenocarcinoma$678,428
R01 · FY2025 · CA
Comparative cost-effectiveness of HCC prevention in metabolic dysfunction associated fatty liver disease$276,775
P01 · FY2025 · CA · contact PI
Risk Stratification for and Early Detection of Liver Cancer$433,960
U01 · FY2024 · CA
Comparative cost-effectiveness of HCC prevention in metabolic dysfunction associated fatty liver disease$251,298
P01 · FY2024 · CA · contact PI
Risk Stratification for and Early Detection of Liver Cancer$963,046
U01 · FY2023 · CA
Comparative cost-effectiveness of HCC prevention in metabolic dysfunction associated fatty liver disease$196,149
P01 · FY2023 · CA · contact PI
Comparative cost-effectiveness of HCC prevention in metabolic dysfunction associated fatty liver disease$201,942
P01 · FY2022 · CA · contact PI